Streetbeat News

Stock Prices

VRCA

In the last quarter, Verrica Pharmaceuticals (NASDAQ:VRCA) received 6 bullish and 1 somewhat bullish ratings from analysts. The company's average 12-month price target has increased by 2.64% from $11.00 to $11.29.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 1:00 pm

FIS

Over the past 3 months, 8 analysts have published their opinion on Fidelity National Info (NYSE:FIS) stock. The company has an average price target of $65.38, a decrease of 8.14% from the previous average price target of $71.17. The analysts' ratings are mixed with 2 bullish, 3 somewhat bullish, and 3 indifferent.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 1:00 pm

WRBY

Warby Parker (NYSE:WRBY) has received various analyst ratings in the last quarter, with 1 bullish, 3 somewhat bullish, and 3 indifferent. Over the past 3 months, 7 analysts have offered 12-month price targets for Warby Parker, with an average price target of $16.43. This average price target has increased by 31.44% over the past month.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 1:00 pm

COUR

Over the past 3 months, 8 analysts have published their opinion on Coursera (NYSE:COUR) stock. The company has an average price target of $18.75, up by 33.93% from the previous average price target of $14.00. The majority of the analysts are somewhat bullish on the stock.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 1:00 pm

REXR

Rexford Industrial Realty (NYSE:REXR) has received four analyst ratings in the last quarter, with an average price target of $61.25, indicating an upside from the current price of $49.91. The average price target has decreased by 12.5% from the previous average of $70.00.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 1:00 pm

BNTX

BioNTech Inc. (NASDAQ:BNTX) is currently trading at $110.80, after a 0.13% decrease. Over the past month, the stock decreased by 2.64%, and in the past year, by 18.30%. The company's P/E ratio is lower than the aggregate P/E of 41.19 of the Biotechnology industry, which could indicate that the stock is undervalued or has weak growth prospects.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 1:00 pm

TPST

Tempest Therapeutics Inc (NASDAQ:TPST) shares are trading lower after the company sold about 1.24 million shares of its common stock for gross proceeds of approximately $7 million. This comes after the stock soared nearly 4,000% on Wednesday due to promising liver cancer treatment data. There is still $93 million remaining under the company's previously announced offering of up to $100 million.

Portfolio Pulse from Adam Eckert

October 12, 2023 | 12:56 pm

EIS

Israeli Prime Minister Benjamin Netanyahu and US Secretary of State Antony Blinken have united against Hamas, comparing the group to ISIS. The US has sent the first shipments of military support to Israel. The Israeli Air Force has launched strikes on over 70 targets in the Gaza Strip. The International Monetary Fund (IMF) is monitoring the situation and its impact on the global economy, particularly oil markets. The Israeli shekel is down 0.3% against the dollar, and the TA-125, Israel’s major stock market index, was down 0.2%. The iShares MSCI Israeli ETF (NYSE:EIS) fell 1.5%.

Portfolio Pulse from Piero Cingari

October 12, 2023 | 12:50 pm

FAST

LL

OPGN

Opgen's unit Curetis received a payment of 750,000 Euros related to the sale of Unyvero A50 Systems, causing OPGN's stock to surge by 1200%. LL Flooring received a $180 million takeover offer from Live Ventures, leading to a 45% increase in LL's stock. Fastenal's Q3 EPS beat estimates but sales missed, resulting in a 5% increase in FAST's stock.

Portfolio Pulse from ryanfaloona@benzinga.com

October 12, 2023 | 12:49 pm

AAPL

NVDA

TSM

XIACF

XIACY

Apple Inc and its key suppliers are facing a significant sales slump despite the recent launch of new devices. Taiwan Semiconductor Manufacturing Co experienced a 13.4% sales drop, while the broader group of major assemblers and component makers saw a decline of 16.4%. The overall decline has resulted in an 8.8% slump for the first nine months of the year. The AI industry's growth, particularly in server sales, is anticipated to double in 2024.

Portfolio Pulse from Anusuya Lahiri

October 12, 2023 | 12:45 pm